Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences, listed under the warrant ticker OACCW, is a blank-check company sponsored by affiliates of Oaktree Capital Management, the Los Angeles-based alternative investment firm with deep roots in credit and private equity. The third SPAC vehicle launched under the Oaktree Acquisition Corp. banner, it targets the life sciences sector, including biotechnology, medical devices, and adjacent healthcare industries. The company filed its annual 10-K with the Securities and Exchange Commission on March 26, 2026, reflecting its continued status as an active blank-check vehicle in search of a merger or acquisition target. Sign up for SpacDesk to access full filings, deal timelines, and analytics on this vehicle and the broader life sciences SPAC pipeline.